Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?

In general, no, I would not use long-term avatrombopag in patients with cirrhosis requiring higher platelet counts for medical therapy due to the perceived thrombotic risk and hemostatic abnormalities of patients with liver disease.

One thing to note in assessing the risk of long-term TPO mimetic the...